BREAKING NEWS FROM F.A.S.T.!!!
click here for: CLINICAL TRIALS ANNOUNCEMENT
“The Foundation for Angelman Syndrome Therapeutics (FAST) is thrilled to report that the University of South Florida (USF) will begin to recruit participants for a new clinical trial led by Edwin Weeber, Ph.D. The Minocycline in the Treatment of Angelman Syndrome Clinical Trial will be conducted at the University of South Florida Health’s Center for Advanced Health Care, 2 Tampa General Circle, Tampa, Florida 33606. A total of twenty-four patients will be randomly selected to participate in this open label trial to determine the efficacy of Minocycline as a treatment for Angelman Syndrome.”